Thoratec’s ProTime
This article was originally published in The Gray Sheet
Executive Summary
CMS national coverage decision will catalyze home-use of blood microcoagulation testing system in $100 mil. market, cardiovascular firm claims June 3. Manufactured and marketed by Thoratec's International Technidyne Corporation (ITC) division, the ProTime measures prothrombin time in patients with a mechanical heart valve and who are taking blood-thinning drugs. Medicare reimbursement is currently available only for testing done at a physician's office or lab. New coverage for the equipment is expected to become effective on July 1, 2002...